디지털 NA(디지털 신경심리검사) 시장 예측(-2034년) : 평가 영역별, 평가 형식별, 환경별, 목적별, 최종사용자별, 지역별 세계 분석

According to Stratistics MRC, the Global Digital Neuropsychological Assessment Market is accounted for $0.8 billion in 2026 and is expected to reach $2.9 billion by 2034 growing at a CAGR of 17.5% during the forecast period. Digital neuropsychological assessment refers to technology-enabled evaluation of cognitive, behavioral, emotional, and neurological functions through computerized tests and digital assessment platforms. These systems measure areas such as memory, attention, processing speed, executive functioning, language, reasoning, and visuospatial abilities using standardized or adaptive assessments. Digital neuropsychological assessment supports clinical evaluation, rehabilitation, research, longitudinal monitoring, and remote assessment while enabling automated data collection and performance analysis. Increasing demand for accessible cognitive testing and advancements in digital healthcare are driving the adoption of digital neuropsychological assessment solutions globally.

Market Dynamics

Driver:

Growing prevalence of neurological conditions

Increasing prevalence of neurological conditions including dementia, traumatic brain injury, stroke, and neurodevelopmental disorders is driving demand for efficient assessment solutions. Advances in digital assessment technology enabling remote, automated, and standardized testing are expanding market accessibility. Growing emphasis on early detection and intervention for cognitive disorders is supporting market growth. Healthcare digitalization and telemedicine adoption are accelerating assessment technology deployment. Early detection enables timely intervention and better outcomes.

Restraint:

Limited reimbursement and regulatory approval

Limited reimbursement and regulatory approval for digital neuropsychological assessments constrain adoption in healthcare settings. Validation requirements for digital assessment tools are extensive and time-consuming. Integration with clinical workflows and electronic health records presents implementation challenges. Equivalence and standardization across digital and traditional assessments remain concerns. Reimbursement pathways are limited in most healthcare systems.

Opportunity:

Integration with telemedicine and remote monitoring

Integration with telemedicine platforms and remote monitoring systems presents significant growth opportunities for assessment providers. Development of culturally and linguistically adapted assessments for diverse populations expands addressable markets. Applications in clinical trials and pharmaceutical research are creating revenue opportunities. Strategic partnerships with healthcare systems and research organizations are accelerating adoption. Remote assessment capabilities are increasingly valued.

Threat:

Competition from traditional neuropsychological assessments

Competition from traditional paper-and-pencil neuropsychological assessments may limit digital assessment adoption. Regulatory uncertainties regarding digital assessment validation pose risks to market development. Data privacy and security concerns may affect patient participation and data sharing. Limited awareness among clinicians and healthcare organizations constrains market growth. Traditional assessments remain the clinical standard in many settings.

Covid-19 Impact:

The COVID-19 pandemic accelerated adoption of remote neuropsychological assessment solutions as in-person testing was restricted during lockdowns. Telehealth and remote assessment capabilities became essential for continuing care and research activities. The post-pandemic period has witnessed sustained acceptance of remote assessments. Growing telehealth infrastructure supports continued digital assessment adoption. Remote assessment has become an established alternative to in-person testing.

The memory segment is expected to be the largest during the forecast period

The memory segment is expected to account for the largest market share during the forecast period as memory assessment represents the most frequently requested neuropsychological evaluation domain in clinical practice. Memory assessment is essential for dementia diagnosis and cognitive disorder evaluation. Established assessment frameworks and normative data support memory assessment dominance. Memory remains the primary focus of neuropsychological evaluations.

The cognitive tasks segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the cognitive tasks segment is predicted to witness the highest growth rate driven by increasing digitalization of performance-based cognitive assessment tasks. Digital cognitive tasks enable automated administration, scoring, and analysis with improved precision. Growing acceptance of computerized cognitive assessment is accelerating platform adoption. Digital tasks offer significant advantages over traditional testing methods.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share owing to advanced healthcare infrastructure, high prevalence of neurological conditions, and early adoption of digital assessment technologies. The United States hosts leading digital neuropsychological assessment providers with established clinical networks. Strong research funding and healthcare investment reinforce regional market leadership. Major healthcare systems are driving adoption across the region.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR driven by growing healthcare investment, increasing prevalence of neurological conditions, and rapid digital health adoption. China, Japan, and India are expanding neuropsychological assessment capabilities. Rising elderly populations and healthcare modernization are accelerating market growth. Healthcare infrastructure development continues across the region.

Key players in the market

Some of the key players in the Digital Neuropsychological Assessment Market include Pearson plc, Cambridge Cognition Holdings plc, Randolph Group Ltd., MedAvante-ProPhase, Inc., Cogstate Ltd., Signant Health, Medidata Solutions, Inc., Clario, IXICO plc, BrainCheck, Inc., CNS Vital Signs, LLC, CogniFit Inc., Neurotrack Technologies, Inc., Altoida, Inc., and NeuroFlow, Inc.

Key Developments:

In May 2025, Cambridge Cognition Holdings plc launched an enhanced digital neuropsychological assessment platform with new cognitive domains and remote administration capabilities. The platform enables comprehensive cognitive assessment across clinical, research, and remote settings. The launch responds to growing demand for digital cognitive assessment solutions.

In March 2025, BrainCheck, Inc. announced significant enhancements to its digital cognitive assessment platform with new features for longitudinal monitoring and clinical decision support. The enhancements strengthen the platform's clinical utility and healthcare integration capabilities.

Assessment Domains Covered:

• Memory
• Attention
• Language
• Executive Function
• Visuospatial Function
• Other Assessment Domains

Assessment Formats Covered:

• Questionnaires
• Cognitive Tasks
• Interactive Tests
• Remote Interviews
• Performance Tests
• Other Assessment Formats

Settings Covered:

• Clinical
• Remote
• Research
• School
• Workplace
• Other Settings

Purposes Covered:

• Screening
• Diagnosis
• Monitoring
• Rehabilitation
• Research
• Other Purposes

End Users Covered:

• Hospitals
• Clinics
• Schools
• Research Centers
• Employers
• Other End Users

Regions Covered:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Netherlands
  • Belgium
  • Sweden
  • Switzerland
  • Poland
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Malaysia
  • Singapore
  • Vietnam
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Colombia
  • Chile
  • Peru
  • Rest of South America
• Rest of the World (RoW)
  • Middle East
• Saudi Arabia
• United Arab Emirates
• Qatar
• Israel
• Rest of Middle East
  • Africa
• South Africa
• Egypt
• Morocco
• Rest of Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

• 1.1 Market Snapshot and Key Highlights
• 1.2 Growth Drivers, Challenges, and Opportunities
• 1.3 Competitive Landscape Overview
• 1.4 Strategic Insights and Recommendations

2 Research Framework

• 2.1 Study Objectives and Scope
• 2.2 Stakeholder Analysis
• 2.3 Research Assumptions and Limitations
• 2.4 Research Methodology
  • 2.4.1 Data Collection (Primary and Secondary)
  • 2.4.2 Data Modeling and Estimation Techniques
  • 2.4.3 Data Validation and Triangulation
  • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

• 3.1 Market Definition and Structure
• 3.2 Key Market Drivers
• 3.3 Market Restraints and Challenges
• 3.4 Growth Opportunities and Investment Hotspots
• 3.5 Industry Threats and Risk Assessment
• 3.6 Technology and Innovation Landscape
• 3.7 Emerging and High-Growth Markets
• 3.8 Regulatory and Policy Environment
• 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

• 4.1 Porter's Five Forces Analysis
  • 4.1.1 Supplier Bargaining Power
  • 4.1.2 Buyer Bargaining Power
  • 4.1.3 Threat of Substitutes
  • 4.1.4 Threat of New Entrants
  • 4.1.5 Competitive Rivalry
• 4.2 Market Share Analysis of Key Players
• 4.3 Product Benchmarking and Performance Comparison

5 Global Digital Neuropsychological Assessment Market, By Assessment Domain

• 5.1 Memory
• 5.2 Attention
• 5.3 Language
• 5.4 Executive Function
• 5.5 Visuospatial Function
• 5.6 Other Assessment Domains

6 Global Digital Neuropsychological Assessment Market, By Assessment Format

• 6.1 Questionnaires
• 6.2 Cognitive Tasks
• 6.3 Interactive Tests
• 6.4 Remote Interviews
• 6.5 Performance Tests
• 6.6 Other Assessment Formats

7 Global Digital Neuropsychological Assessment Market, By Setting

• 7.1 Clinical
• 7.2 Remote
• 7.3 Research
• 7.4 School
• 7.5 Workplace
• 7.6 Other Settings

8 Global Digital Neuropsychological Assessment Market, By Purpose

• 8.1 Screening
• 8.2 Diagnosis
• 8.3 Monitoring
• 8.4 Rehabilitation
• 8.5 Research
• 8.6 Other Purposes

9 Global Digital Neuropsychological Assessment Market, By End User

• 9.1 Hospitals
• 9.2 Clinics
• 9.3 Schools
• 9.4 Research Centers
• 9.5 Employers
• 9.6 Other End Users

10 Global Digital Neuropsychological Assessment Market, By Geography

• 10.1 North America
  • 10.1.1 United States
  • 10.1.2 Canada
  • 10.1.3 Mexico
• 10.2 Europe
  • 10.2.1 United Kingdom
  • 10.2.2 Germany
  • 10.2.3 France
  • 10.2.4 Italy
  • 10.2.5 Spain
  • 10.2.6 Netherlands
  • 10.2.7 Belgium
  • 10.2.8 Sweden
  • 10.2.9 Switzerland
  • 10.2.10 Poland
  • 10.2.11 Rest of Europe
• 10.3 Asia Pacific
  • 10.3.1 China
  • 10.3.2 Japan
  • 10.3.3 India
  • 10.3.4 South Korea
  • 10.3.5 Australia
  • 10.3.6 Indonesia
  • 10.3.7 Thailand
  • 10.3.8 Malaysia
  • 10.3.9 Singapore
  • 10.3.10 Vietnam
  • 10.3.11 Rest of Asia Pacific
• 10.4 South America
  • 10.4.1 Brazil
  • 10.4.2 Argentina
  • 10.4.3 Colombia
  • 10.4.4 Chile
  • 10.4.5 Peru
  • 10.4.6 Rest of South America
• 10.5 Rest of the World (RoW)
  • 10.5.1 Middle East
    • 10.5.1.1 Saudi Arabia
    • 10.5.1.2 United Arab Emirates
    • 10.5.1.3 Qatar
    • 10.5.1.4 Israel
    • 10.5.1.5 Rest of Middle East
  • 10.5.2 Africa
    • 10.5.2.1 South Africa
    • 10.5.2.2 Egypt
    • 10.5.2.3 Morocco
    • 10.5.2.4 Rest of Africa

11 Strategic Market Intelligence

• 11.1 Industry Value Network and Supply Chain Assessment
• 11.2 White-Space and Opportunity Mapping
• 11.3 Product Evolution and Market Life Cycle Analysis
• 11.4 Channel, Distributor, and Go-to-Market Assessment

12 Industry Developments and Strategic Initiatives

• 12.1 Mergers and Acquisitions
• 12.2 Partnerships, Alliances, and Joint Ventures
• 12.3 New Product Launches and Certifications
• 12.4 Capacity Expansion and Investments
• 12.5 Other Strategic Initiatives

13 Company Profiles

• 13.1 Pearson plc
• 13.2 Cambridge Cognition Holdings plc
• 13.3 Randolph Group Ltd.
• 13.4 MedAvante-ProPhase, Inc.
• 13.5 Cogstate Ltd.
• 13.6 Signant Health
• 13.7 Medidata Solutions, Inc.
• 13.8 Clario
• 13.9 IXICO plc
• 13.10 BrainCheck, Inc.
• 13.11 CNS Vital Signs, LLC
• 13.12 CogniFit Inc.
• 13.13 Neurotrack Technologies, Inc.
• 13.14 Altoida, Inc.
• 13.15 NeuroFlow, Inc.